Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

EUFOREA summit in Brussels 2023 : inspiring the future of allergy & respiratory care

Hellings, P. W. ; Lau, S. ; Scadding, G. K. ; Bjermer, L. LU ; Backer, V. ; Chaker, A. M. ; Conti, D. M. ; De Corso, E. ; Diamant, Z. LU and Djukanovic, R. , et al. (2023) In Frontiers in Allergy 4.
Abstract

In March 2023, the European Forum for Research and Education in Allergy and Airways diseases (EUFOREA) organized its bi-annual Summit in Brussels with expert panel members of EUFOREA, representatives of the EUFOREA patient advisory board, and the EUFOREA board and management teams. Its aim was to define the research, educational and advocacy initiatives to be developed by EUFOREA over the next 2 years until the 10th anniversary in 2025. EUFOREA is an international non-for-profit organization forming an alliance of all stakeholders dedicated to reducing the prevalence and burden of chronic allergic and respiratory diseases via research, education, and advocacy. Based on its medical scientific core competency, EUFOREA offers an... (More)

In March 2023, the European Forum for Research and Education in Allergy and Airways diseases (EUFOREA) organized its bi-annual Summit in Brussels with expert panel members of EUFOREA, representatives of the EUFOREA patient advisory board, and the EUFOREA board and management teams. Its aim was to define the research, educational and advocacy initiatives to be developed by EUFOREA over the next 2 years until the 10th anniversary in 2025. EUFOREA is an international non-for-profit organization forming an alliance of all stakeholders dedicated to reducing the prevalence and burden of chronic allergic and respiratory diseases via research, education, and advocacy. Based on its medical scientific core competency, EUFOREA offers an evidence-supported platform to introduce innovation and education in healthcare leading to optimal patient care, bridging the gap between latest scientific evidence and daily practice. Aligned with the mission of improving health care, the expert panels of asthma, allergic rhinitis (AR), chronic rhinosinusitis (CRS) & European Position Paper on Rhinosinusitis and Nasal Polyps (EPOS), allergen immunotherapy (AIT) and paediatrics have proposed and elaborated a variety of activities that correspond to major unmet needs in the allergy and respiratory field. The current report provides a concise overview of the achievements, ambitions, and action plan of EUFOREA for the future, allowing all stakeholders in the allergy and respiratory field to be up-dated and inspired to join forces in Europe and beyond.

(Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; ; and , et al. (More)
; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; and (Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
allergen immunotherapy, allergic rhinitis, asthma, EUFOREA, paediatrics, patient advisory board, pocket guide, rhinosinusitis
in
Frontiers in Allergy
volume
4
article number
1236977
publisher
Frontiers Media S. A.
external identifiers
  • pmid:37577332
  • scopus:85167606641
ISSN
2673-6101
DOI
10.3389/falgy.2023.1236977
language
English
LU publication?
yes
id
17d7d994-0678-4c6c-9858-a596d95fcf41
date added to LUP
2023-11-21 14:17:02
date last changed
2024-06-28 00:00:58
@article{17d7d994-0678-4c6c-9858-a596d95fcf41,
  abstract     = {{<p>In March 2023, the European Forum for Research and Education in Allergy and Airways diseases (EUFOREA) organized its bi-annual Summit in Brussels with expert panel members of EUFOREA, representatives of the EUFOREA patient advisory board, and the EUFOREA board and management teams. Its aim was to define the research, educational and advocacy initiatives to be developed by EUFOREA over the next 2 years until the 10th anniversary in 2025. EUFOREA is an international non-for-profit organization forming an alliance of all stakeholders dedicated to reducing the prevalence and burden of chronic allergic and respiratory diseases via research, education, and advocacy. Based on its medical scientific core competency, EUFOREA offers an evidence-supported platform to introduce innovation and education in healthcare leading to optimal patient care, bridging the gap between latest scientific evidence and daily practice. Aligned with the mission of improving health care, the expert panels of asthma, allergic rhinitis (AR), chronic rhinosinusitis (CRS) &amp; European Position Paper on Rhinosinusitis and Nasal Polyps (EPOS), allergen immunotherapy (AIT) and paediatrics have proposed and elaborated a variety of activities that correspond to major unmet needs in the allergy and respiratory field. The current report provides a concise overview of the achievements, ambitions, and action plan of EUFOREA for the future, allowing all stakeholders in the allergy and respiratory field to be up-dated and inspired to join forces in Europe and beyond.</p>}},
  author       = {{Hellings, P. W. and Lau, S. and Scadding, G. K. and Bjermer, L. and Backer, V. and Chaker, A. M. and Conti, D. M. and De Corso, E. and Diamant, Z. and Djukanovic, R. and Fokkens, W. and Gevaert, P. and Gray, C. L. and Han, J. K. and Heaney, L. G. and Hoffmann, H. J. and Jesenak, M. and Johansen, P. and Kumaran, M. S. and McDonald, M. and Melén, E. and Mullol, J. and Reitsma, S. and Ryan, D. and Scadding, G. and Schmid-Grendelmeier, P. and Teeling, T. and Odemyr, M. and Wahn, U.}},
  issn         = {{2673-6101}},
  keywords     = {{allergen immunotherapy; allergic rhinitis; asthma; EUFOREA; paediatrics; patient advisory board; pocket guide; rhinosinusitis}},
  language     = {{eng}},
  publisher    = {{Frontiers Media S. A.}},
  series       = {{Frontiers in Allergy}},
  title        = {{EUFOREA summit in Brussels 2023 : inspiring the future of allergy & respiratory care}},
  url          = {{http://dx.doi.org/10.3389/falgy.2023.1236977}},
  doi          = {{10.3389/falgy.2023.1236977}},
  volume       = {{4}},
  year         = {{2023}},
}